Hudson Bay Capital Management LP - VERTEX PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F900. A total of 6 filers reported holding VERTEX PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
Hudson Bay Capital Management LP ownership history of VERTEX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$29,432,000
+172.4%
160,000
+145.4%
0.38%
+161.4%
Q4 2018$10,804,000
-63.3%
65,200
-57.3%
0.14%
-60.2%
Q3 2018$29,451,000
+861.8%
152,800
+445.7%
0.36%
+787.8%
Q1 2017$3,062,000–28,000–0.04%–
 Download
Other shareholders
VERTEX PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 99,400$34,565,3560.12%
SIMPLEX TRADING, LLC 61,500$21,3860.02%
IMC-Chicago, LLC 47,900$16,656,7460.02%
JANE STREET GROUP, LLC 119,000$41,381,0600.01%
Allianz Asset Management GmbH 19,700$6,850,4780.01%
SG Americas Securities, LLC 59,600$5930.01%
Maven Securities LTD 900$312,9660.00%
JPMORGAN CHASE & CO 40,500$14,083,4700.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
OSAIC HOLDINGS, INC. 1$5,4200.00%
View complete list of VERTEX PHARMACEUTICALS INC shareholders